Dr. Anh NGUYEN, MBA, PhD
President of MedinCell

Anh is the main founder of MedinCell, and from 2002 to 2007, acted as Chief Scientific Officer. Formerly, co-founder of SYNTRO (IPO NASDAQ, 1987) and INVITROGEN (IPO NASDAQ, 1995), he is a molecular biologist (PhD UCSD), who also followed the US MBA Sloan MIT Program. MedinCell is Anh’s third biotechnology company in which he has direct executive management role after SYNTRO and INVITROGEN



François Henry d’ARRAS, MBA
Vice President Finance And Administration - CEO

François Henry  is the Chief Executive Officer of MedinCell since 2004. Former CFO of the French Red Cross, he received his MBA at the High Economic School of Paris (H.E.C.) and is an expert in financial optimization and IPOs.



Dr. Alexandre MELIN, PhD
Vice President Business Development

Alexandre is in charge of Business Development since 2006. Physiologist, pharmacologist and clinical investigator, he developed a business unit in a European CRO before joining MedinCell.



Dr. Georges GAUDRIAULT, PhD
Vice President R&D - CSO

Georges is the Chief Scientific Officer of MedinCell since 2007. Former CSO of various biotech companies in the USA and in France, he received his PhD at the University of Sophia Antipolis (France). Georges is expert in biochemistry and management of high level pharmacological R&D programs.